The Food and Drug Administration yesterday released new draft guidance for labeling medications that carry the risk of abuse or dependence, including but not limited to opioids, and simplifying labels with complicated usage instructions. Changes for potentially habit-forming drugs include defining terminology, such as abuse, misuse, addiction, physical dependence and tolerance, to avoid misinterpretation on labels. According to the guidance, opioid-specific labeling should include information about how health care professionals can safely decrease the dosage in physically dependent patients, with a goal of finding the balance in pain management and reduced use. For medications with detailed instructions for use, the FDA recommends patient-friendly visual guides that are consistent in content and format.

Related News Articles

Headline
The Health Resources and Services Administration yesterday awarded 80 rural consortia $1 million each to help prevent, treat and support recovery for patients…
Headline
The National Association of Attorneys General yesterday urged congressional leaders to remove federal barriers to opioid use disorder treatment.
Headline
The number of naloxone prescriptions dispensed from retail pharmacies doubled in 2018, but access to the emergency opioid overdose treatment still varies…
Headline
The Department of Health and Human Services seeks input from health care providers and other stakeholders for a report to Congress on ensuring legitimate…
Headline
The Department of Health and Human Services yesterday sent Congress its plan to help states develop and expand innovative strategies to provide housing-related…
Headline
Qualified nonprofits and government agencies may submit through Aug. 25 letters of intent to apply for funding from the Foundation for Opioid Response Efforts…